The overexpression of CCL5 and/or its receptor CCR5 in various tumor cells (e.g. breast cancer,168 acute lymphocytic leukemia,169 multiple myeloma (MM),170 Hodgkin lymphoma,171 colorectal carcinoma172) has long been elucidated. Here, CCR5 is linked to neoplasm.